Skip to content
GLP-1 Scorecard
Menu
Graded #299

Call-On-Doc

Call-On-Doc is a large multi-condition online telehealth service (2M+ patients, 800k+ five-star reviews) offering a GLP-1 weight-loss program.

Visit Call-On-DocWe may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Semaglutide
Not disclosed
Tirzepatide
Not disclosed
Coverage
All 50 states
Brand-name
Yes

Line Call-On-Doc up against its closest alternatives.

Factor breakdown

Each of the six graded dimensions. See the methodology.

Cost value45/100
Dose & formulation53/100
Clinical oversight85/100
Labs & monitoring54/100
Fulfillment83/100
Contract terms55/100

Strengths

  • Prescribes branded GLP-1s (Wegovy, Ozempic, Mounjaro, Zepbound, Saxenda)
  • Available in all 50 states plus DC
  • Fast, no-appointment visits usually completed within two hours
  • Patients can use insurance at the pharmacy plus an Rx savings card
  • Large, well-reviewed platform (2M+ patients, 800k+ 5-star reviews)

Where it loses points

  • Specific visit fee and medication pricing not posted on homepage
  • Credit card required for the visit fee
  • Multi-condition focus rather than weight-loss specialist
  • Provider credentials described only generically

Bottom line — Grade C

Best for: Patients wanting fast, no-appointment branded GLP-1 access with pharmacy insurance use.

Ranked #299 of 499 on this scorecard. See our top-scoring pick, CoreAge Rx (#1), for comparison.

Closest on the board

The boards grading nearest Call-On-Doc — the realistic shortlist.

The 21 boards nearest this one

View full scorecard rankings →

Pricing/verification reflect Call-On-Doc's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Call-On-Doc's site. Not medical advice; see our disclosure.

← Back to the scorecard